Key facts
- Paradigm Biocapital Advisors LP filed SCHEDULE 13G/A for Arcellx, Inc. Common Stock, $0.001 par value per share (ACLX).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2025.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | 9.9% | 5,724,016 | 5,724,016 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Paradigm BioCapital Advisors GP LLC | 9.9% | 5,724,016 | 5,724,016 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Senai Asefaw, M.D. | 9.9% | 5,724,016 | 5,724,016 | 0 | /s/ Senai Asefaw, M.D. | N/A | |
| Paradigm BioCapital International Fund Ltd. | 8.7% | 5,055,581 | 5,055,581 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory |
CIK / CUSIP context first